CD86 and neoplasm: At the same time, the reduction in tumor Treg prevents the downregulation of costimulatory B7-family proteins (CD80 and CD86) on cDC in a CTLA-4-dependent manner (Qureshi et al., 2011; Wing et al., 2008).